Cash flow AXA

Equities

CS

FR0000120628

Life & Health Insurance

Market Closed - Euronext Paris Other stock markets 11:35:02 2025-01-20 am EST			After market 01:38:00 pm
35.34 ^EUR	-0.06%		35.24	-0.28%

Jan. 17	AXA : JP Morgan keeps its Buy rating	ZD
Jan. 15	AXA : Receives a Buy rating from Jefferies	ZD

34637774b3a946f2f90d4f.tbpOUQt7TFl5IZtu9eRDwH7PMBtIRAK276d_SMtiKRk.5NUefFsaIG40F_EclNcigj39e3ALcGvw3u06cJgFQyqN2yAXSQ8iAEtuow

Published financial data: AXA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Premiums and Annuity Revenues	98.31B	93.58B	96.32B	99.29B	80.89B
Total Interest And Dividend Income	12.12B	12.17B	12.16B	12.2B	-2.16B
Gain (Loss) on Sale of Investments, Total (Rev)	19B	3.78B	10.58B	-10.72B	5.68B
Non-Insurance Activities Revenues	512M	486M	535M	237M	-
Other Revenues, Total	3.17B	2.32B	2.57B	2.69B	2.74B
Total Revenues	133B	112B	122B	104B	87.15B
Policy Benefits	103B	83.61B	88.43B	71.43B	73.96B
Policy Acquisition / Underwriting Costs, Total	13.13B	12.63B	13.05B	12.76B	-
Amortization of Goodwill and Intangible Assets - (IS)	38M	110M	41M	135M	-
Selling General & Admin Expenses, Total	10.72B	10.72B	10.39B	10.36B	-
Other Operating Expenses	598M	-251M	461M	-348M	3.94B
Non-Insurance Activities Expenses	67M	79M	63M	13M	-
Total Operating Expenses	127B	107B	112B	94.36B	77.9B
Operating Income	5.96B	5.44B	9.73B	9.34B	9.26B
Interest Expense, Total	-720M	-878M	-462M	-477M	-609M
Income (Loss) on Equity Invest.	504M	400M	144M	-141M	277M
Other Non Operating Income (Expenses)	0	-3M	0	2M	1M
EBT, Excl. Unusual Items	5.74B	4.96B	9.42B	8.72B	8.92B
Impairment of Goodwill	-	-28M	-	-	-
Asset Writedown	-115M	-64M	-218M	7M	-1M
Other Unusual Items	-	-	-	-19M	-37M
EBT, Incl. Unusual Items	5.62B	4.87B	9.2B	8.71B	8.89B
Income Tax Expense	1.42B	1.54B	1.69B	1.86B	1.51B
Earnings From Continuing Operations	4.21B	3.33B	7.51B	6.86B	7.37B
Earnings Of Discontinued Operations	-24M	-	-	-	-
Net Income to Company	4.18B	3.33B	7.51B	6.86B	7.37B
Minority Interest	-325M	-167M	-214M	-180M	-184M
Net Income - (IS)	3.86B	3.16B	7.29B	6.68B	7.19B
Preferred Dividend and Other Adjustments	254M	177M	194M	182M	185M
Net Income to Common Incl Extra Items	3.6B	2.99B	7.1B	6.49B	7B
Net Income to Common Excl. Extra Items	3.63B	2.99B	7.1B	6.49B	7B
Per Share Items
Net EPS - Basic	1.51	1.25	2.98	2.84	3.14
Basic EPS - Continuing Operations	1.52	1.25	2.98	2.84	3.14
Basic Weighted Average Shares Outstanding	2.38B	2.38B	2.38B	2.29B	2.23B
Net EPS - Diluted	1.51	1.25	2.97	2.83	3.13
Diluted EPS - Continuing Operations	1.52	1.25	2.97	2.83	3.13
Diluted Weighted Average Shares Outstanding	2.39B	2.39B	2.39B	2.3B	2.24B
Normalized Basic EPS	1.37	1.23	2.38	2.3	2.42
Normalized Diluted EPS	1.37	1.23	2.37	2.29	2.41
Dividend Per Share	0.73	1.43	1.54	1.7	1.98
Payout Ratio	84.73	55.09	47.83	59.42	58.39
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	7.33B	6.62B	10.6B	10.21B	-
EBITA	6.1B	5.62B	9.98B	9.47B	9.37B
EBIT	5.96B	5.44B	9.73B	9.34B	9.26B
Effective Tax Rate - (Ratio)	25.23	31.63	18.36	21.3	17.03
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	1.38B	1.43B	1.39B	1.67B	1.26B
Deferred Domestic Taxes	-	-	-	-	-
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	43M	110M	301M	186M	255M
Normalized Net Income	3.26B	2.94B	5.67B	5.27B	5.39B
Non-Cash Pension Expense	66M	27M	30M	17M	91M
Supplemental Operating Expense Items
General and Administrative Expenses	10.72B	10.72B	10.39B	10.36B	-
Stock-Based Comp., Other (Total)	185M	165M	192M	180M	198M
Total Stock-Based Compensation	185M	165M	192M	180M	198M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Investment In Debt Securities	419B	429B	397B	302B	312B
Investment In Equity and Preferred Securities, Total	33.55B	33.34B	38.82B	32.18B	15.18B
Trading Asset Securities, Total	150M	319M	1M	4M	16.11B
Real Estate Owned	26.61B	30.29B	31.02B	31.73B	32.54B
Mortgage Loans	-	-	-	-	-
Total Other Investments	30.36B	31.2B	36.76B	39B	40.82B
Total investments	509B	524B	504B	405B	417B
Cash And Equivalents	21.95B	28.24B	25.05B	26.16B	24.97B
Reinsurance Recoverable - (IS)	27.4B	30.89B	41.12B	45.52B	25.21B
Other Receivables - (Insurance Template)	62.61B	61.18B	60.89B	64.26B	37.82B
Deferred Policy Acquisition Costs - (BS)	16.68B	16.53B	17.82B	26.3B	-
Separate Account Assets	72.66B	77.8B	86.32B	76.47B	82.75B
Net Property Plant And Equipment	2.87B	2.65B	2.44B	2.23B	2.1B
Goodwill	17.78B	16.58B	17.17B	17.75B	17.86B
Other Intangibles, Total	4.87B	4.43B	4.3B	4.29B	4.22B
Other Current Assets, Total	41.04B	38.96B	13.47B	21.36B	26.22B
Deferred Tax Assets Long-Term (Collected)	651M	333M	421M	4.15B	3.48B
Deferred Charges Long-Term	-	-	-	-	407M
Other Long-Term Assets, Total	2.96B	2.72B	2.51B	2.9B	2.49B
Total Assets	781B	805B	775B	697B	644B
Liabilities
Accrued Expenses, Total	102M	81M	93M	95M	84M
Insurance And Annuity Liabilities	357B	368B	356B	306B	457B
Unpaid Claims	95.94B	98.44B	104B	109B	-
Unearned Premiums	24.6B	22.98B	23.92B	24.68B	-
Reinsurance Payable - (BS)	12.22B	14.08B	16.47B	16.92B	8M
Current Portion of Long-Term Debt	28.71B	33.96B	29.54B	32.62B	34.48B
Short-Term Borrowings	679M	1.52B	1.18B	984M	994M
Long-Term Debt	30.53B	30.12B	30.47B	29.79B	24.07B
Long-Term Leases	1.6B	-	-	-	-
Separate Account Liability	73.15B	78.08B	86.36B	76.72B	12.11B
Current Income Taxes Payable	1.17B	1.09B	924M	1.26B	1.28B
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	43.07B	40.99B	16.35B	19.95B	33.91B
Pension & Other Post Retirement Benefits	8.41B	8.45B	7.48B	4.57B	3.52B
Deferred Tax Liability Non-Current	5.84B	6.47B	5.33B	1.43B	1.74B
Other Non Current Liabilities	14.81B	14.69B	14.21B	17.16B	15.38B
Total Liabilities	698B	719B	693B	642B	584B
Common Stock, Total	5.54B	5.54B	5.54B	5.39B	22.13B
Additional Paid In Capital	21.71B	21.74B	21.8B	20.16B	-
Retained Earnings	19.3B	20.28B	24.7B	28.18B	33.14B
Treasury Stock	-752M	-744M	-1.63B	-2.15B	-
Comprehensive Income and Other	24.11B	24.81B	20.72B	-6.22B	-5.69B
Total Common Equity	69.9B	71.61B	71.14B	45.35B	49.58B
Minority Interest	13.3B	13.79B	11.84B	9.42B	10.41B
Total Equity	83.19B	85.4B	82.98B	54.78B	59.99B
Total Liabilities And Equity	781B	805B	775B	697B	644B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.39B	2.39B	2.36B	2.26B	2.23B
ECS Total Common Shares Outstanding	2.39B	2.39B	2.36B	2.26B	2.23B
Book Value / Share	29.29	30.01	30.2	20.03	22.27
Tangible Book Value	47.25B	50.6B	49.67B	23.31B	27.5B
Tangible Book Value Per Share	19.8	21.21	21.09	10.29	12.35
Total Debt	61.51B	65.59B	61.2B	63.39B	59.54B
Net Debt	39.56B	37.35B	36.15B	37.23B	34.57B
Debt Equivalent of Unfunded Proj. Benefit Obligation	6.73B	6.74B	5.48B	1.44B	655M
Minority Interest, Total (Incl. Fin. Div)	13.3B	13.79B	11.84B	9.42B	10.41B
Equity Method Investments, Total	2.44B	2.47B	2.6B	2.43B	1.94B
Account Code - Inventory Valuation	3	3	3	3	3
Full Time Employees	115K	110K	106K	92.7K	94.7K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	3.86B	3.16B	7.29B	6.68B	7.19B
Depreciation, Depletion & Amortization	1.23B	1.01B	624M	-293M	-674M
Amortization of Goodwill and Intangible Assets - (CF)	146M	170M	246M	130M	112M
Total Depreciation, Depletion & Amortization	1.38B	1.18B	870M	-163M	-562M
(Gain) Loss on Sale of Investments - (CF)	-18.96B	-3.76B	-10.64B	10.68B	3.34B
Total Asset Writedown	115M	87M	212M	-	-9.03B
(Income) Loss On Equity Investments - (CF)	-497M	-400M	-144M	152M	-277M
Change in Accounts Receivable	562M	9.47B	4.34B	956M	4.91B
Change in Other Net Operating Assets (Collected)	-114M	908M	-1.81B	-1.58B	-1.14B
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities	22.52B	14.89B	6.4B	-8.83B	2.01B
Cash from Operations	8.86B	25.53B	6.53B	7.88B	6.44B
Capital Expenditure	-462M	-389M	-350M	-353M	-427M
Sale of Property, Plant, and Equipment	75M	3M	6M	33M	21M
Cash Acquisitions	-242M	-18M	24M	-34M	-809M
Divestitures	293M	888M	-1.11B	315M	-46M
Sale (Purchase) of Real Estate Properties (Collected)	-2.45B	-2.06B	-2.19B	-622M	28M
Investment in Marketable and Equity Securities, Total	-13.36B	-6.66B	4.76B	9.18B	5.32B
Net (Increase) Decrease in Loans Originated / Sold - Investing	647M	-2.49B	-7.26B	-8.08B	-4.03B
Other Investing Activities, Total	4.83B	-707M	-2.83B	36M	-1.66B
Cash from Investing	-10.66B	-11.43B	-8.95B	470M	-1.6B
Long-Term Debt Issued, Total	145M	-	1.02B	3.36B	1.75B
Total Debt Issued	145M	-	1.02B	3.36B	1.75B
Long-Term Debt Repaid, Total	-781M	-1.82B	-116M	-1.54B	-1.94B
Total Debt Repaid	-781M	-1.82B	-116M	-1.54B	-1.94B
Issuance of Common Stock	-	71M	279M	335M	362M
Repurchase of Common Stock	-2.06B	-280M	-1.31B	-3.99B	-2.15B
Common Dividends Paid	-3.27B	-1.74B	-3.49B	-3.97B	-4.2B
Common & Preferred Stock Dividends Paid	-3.27B	-1.74B	-3.49B	-3.97B	-4.2B
Other Financing Activities, Total	-1.04B	-1.16B	-720M	-329M	-599M
Cash from Financing	-7.01B	-4.93B	-4.33B	-6.12B	-6.78B
Foreign Exchange Rate Adjustments	471M	-737M	202M	-430M	-151M
Miscellaneous Cash Flow Adjustments	-943M	-2.9B	3.41B	-489M	539M
Net Change in Cash	-9.29B	5.54B	-3.14B	1.31B	-1.55B
Supplemental Items
Cash Interest Paid	889M	1.16B	718M	329M	5.36B
Cash Income Tax Paid (Refund)	978M	1.36B	1.53B	1.34B	1.08B
Net Debt Issued / Repaid	-636M	-1.82B	906M	1.82B	-194M
Levered Free Cash Flow	1.73B	2.69B	6.4B	2.33B	3.73B
Unlevered Free Cash Flow	2.18B	3.24B	6.69B	2.63B	4.11B
Change In Net Working Capital	2.65B	1.12B	104M	2.87B	882M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	0.43	0.43	0.77	0.79	0.9
Return on Total Capital	2.63	2.32	4.12	4.45	4.85
Return On Equity %	5.15	3.95	8.92	9.95	12.77
Return on Common Equity	5.48	4.22	9.95	11.15	14.64
Margin Analysis
Gross Profit Margin %	13.01	14.26	16.88	18.79	15.14
SG&A Margin	8.06	9.54	8.5	10	-
EBITDA Margin %	5.51	5.89	8.68	9.84	-
EBITA Margin %	4.58	5	8.17	9.13	10.75
EBIT Margin %	4.47	4.85	7.97	9	10.62
Income From Continuing Operations Margin %	3.16	2.96	6.15	6.61	8.46
Net Income Margin %	2.9	2.82	5.97	6.44	8.25
Net Avail. For Common Margin %	2.72	2.66	5.81	6.26	8.04
Normalized Net Income Margin	2.45	2.61	4.64	5.08	6.19
Levered Free Cash Flow Margin	1.3	2.4	5.24	2.25	4.28
Unlevered Free Cash Flow Margin	1.63	2.88	5.48	2.53	4.72
Asset Turnover
Asset Turnover	0.16	0.14	0.15	0.14	0.14
Fixed Assets Turnover	59.54	40.69	47.99	44.37	40.29
Receivables Turnover (Average Receivables)	5.27	4.89	5.13	5.17	10.5K
Short Term Liquidity
Current Ratio	0.58	0.6	0.56	0.59	1.42
Quick Ratio	0.25	0.27	0.28	0.27	0.69
Operating Cash Flow to Current Liabilities	0.04	0.12	0.03	0.04	0.09
Days Sales Outstanding (Average Receivables)	69.26	74.83	71.09	70.57	0.03
Average Days Payable Outstanding	336.45	419.24	418.37	534.28	0.03
Long Term Solvency
Total Debt/Equity	73.94	76.81	73.75	115.73	99.25
Total Debt / Total Capital	42.51	43.44	42.45	53.65	49.81
LT Debt/Equity	38.62	35.27	36.72	54.39	40.12
Long-Term Debt / Total Capital	22.2	19.95	21.14	25.21	20.14
Total Liabilities / Total Assets	89.35	89.39	89.3	92.14	90.69
EBIT / Interest Expense	8.27	6.2	21.07	19.58	15.2
EBITDA / Interest Expense	10.18	7.54	22.95	21.4	-
(EBITDA - Capex) / Interest Expense	9.54	7.1	22.19	20.66	-
Total Debt / EBITDA	8.39	9.91	5.77	6.21	-
Net Debt / EBITDA	5.4	5.64	3.41	3.65	-
Total Debt / (EBITDA - Capex)	8.95	10.52	5.97	6.43	-
Net Debt / (EBITDA - Capex)	5.76	5.99	3.53	3.78	-
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	25.07	-15.6	8.74	-15.12	0.41
Gross Profit, 1 Yr. Growth %	-10.43	-7.47	28.72	-5.48	17.22
EBITDA, 1 Yr. Growth %	-18.39	-9.7	60.14	-3.73	-
EBITA, 1 Yr. Growth %	-26.06	-7.98	77.72	-5.12	24.12
EBIT, 1 Yr. Growth %	-26.79	-8.58	78.75	-4.06	24.8
Earnings From Cont. Operations, 1 Yr. Growth %	7.55K	-20.8	125.4	-8.7	41.6
Net Income, 1 Yr. Growth %	80.23	-17.97	130.53	-8.49	42.05
Normalized Net Income, 1 Yr. Growth %